Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maher Albitar

Showing results (101-110 of 214) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|July 13, 2010
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation studyPaul G Richardson, Asher A Chanan-Khan, Melissa Alsina, et al.
Cancer|January 30, 2002
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndromeRaymond Lai, Elihu Estey, Yu Shen, et al.
Cancer|April 7, 2006
Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignanciesBarry D Hock, Judith L McKenzie, Nigel W Patton, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 9, 2011
Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomasAziza Nassar, Cynthia Cohen, Maher Albitar, et al.
British Journal of Haematology|July 13, 2010
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myelomaPaul G Richardson, Ashraf Z Badros, Sundar Jagannath, et al.
Plos One|August 24, 2010
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasmsWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Transplantation and Cellular Therapy|August 27, 2025
Peripheral Blood Tumor Associated Cell-Free DNA Testing As a Predictor for Relapse Post-Allogeneic Stem Cell Transplant for AMLVanisha Patel, Maciej Kabat, Andrew Ip, et al.
Blood|October 25, 2003
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasiaAnna Rogers, Youngson Joe, Taghi Manshouri, et al.
European Journal of Haematology|August 22, 2003
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myelomaMaha Ahmed, Francis Giles, Youngson Joe, et al.
Pageof 22

Showing results (101-110 of 214) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|July 13, 2010
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation studyPaul G Richardson, Asher A Chanan-Khan, Melissa Alsina, et al.
Cancer|January 30, 2002
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndromeRaymond Lai, Elihu Estey, Yu Shen, et al.
Cancer|April 7, 2006
Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignanciesBarry D Hock, Judith L McKenzie, Nigel W Patton, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 9, 2011
Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomasAziza Nassar, Cynthia Cohen, Maher Albitar, et al.
British Journal of Haematology|July 13, 2010
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myelomaPaul G Richardson, Ashraf Z Badros, Sundar Jagannath, et al.
Plos One|August 24, 2010
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasmsWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Transplantation and Cellular Therapy|August 27, 2025
Peripheral Blood Tumor Associated Cell-Free DNA Testing As a Predictor for Relapse Post-Allogeneic Stem Cell Transplant for AMLVanisha Patel, Maciej Kabat, Andrew Ip, et al.
Blood|October 25, 2003
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasiaAnna Rogers, Youngson Joe, Taghi Manshouri, et al.
European Journal of Haematology|August 22, 2003
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myelomaMaha Ahmed, Francis Giles, Youngson Joe, et al.
Pageof 22